Northwestern Mutual Wealth Management
MLNT

Northwestern Mutual Wealth Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-381
Closed – – 2870
2019
Q4 		$0 Hold
381
– – ﹤0.01% 2749
2019
Q3 		$1K Hold
381
– – ﹤0.01% 2438
2019
Q2 		$3K Hold
381
– – ﹤0.01% 2281
2019
Q1 		$1K Hold
381
– – ﹤0.01% 2495
2018
Q4 		$2K Hold
381
– – ﹤0.01% 2242
2018
Q3 		$8K Buy
381
+30
+9% +$758 ﹤0.01% 2008
2018
Q2 		$11K Hold
351
– – ﹤0.01% 1824
2018
Q1 		$13K Hold
351
– – ﹤0.01% 1689
2017
Q4 		$28K Buy
+351
New +$26K ﹤0.01% 1397

Northwestern Mutual Wealth Management's MLNT Position: Q1 2020 in Review

Northwestern Mutual Wealth Management sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 381 shares.

Northwestern Mutual Wealth Management first reported a position in MLNT in Q4 2017 and held it in 9 quarters. The position peaked at $28K in Q4 2017. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

  • Northwestern Mutual Wealth Management reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 381 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020.
  • Northwestern Mutual Wealth Management first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
  • Northwestern Mutual Wealth Management's Melinta Therapeutics, Inc. Common Stock position peaked at $28K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2020, filed 8 May 2020.